021-51111890
购物车（）
sales@molnova.cn
Nafoxidine
CAS No. 1845-11-0
Nafoxidine ( —— )
产品货号. M27396 CAS No. 1845-11-0
Nafoxidine is an estrogen antagonist that has been used in the treatment of breast cancer.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ￥2722 | 有现货 |
|
| 10MG | ￥4026 | 有现货 |
|
| 25MG | ￥6423 | 有现货 |
|
| 50MG | ￥9153 | 有现货 |
|
| 100MG | ￥12312 | 有现货 |
|
| 500MG | ￥24057 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Nafoxidine
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述Nafoxidine is an estrogen antagonist that has been used in the treatment of breast cancer.
-
产品描述Nafoxidine is an estrogen antagonist that has been used in the treatment of breast cancer.
-
同义词——
-
通路Endocrinology/Hormones
-
靶点Estrogen Receptor/ERR
-
受体——
-
研究领域——
-
适应症——
化学信息
-
CAS Number1845-11-0
-
分子量425.6
-
分子式C29H31NO2
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESCOc1ccc2C(=C(CCc2c1)c1ccccc1)c1ccc(OCCN2CCCC2)cc1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Siqin Zhaorigetu, et al. Perturbations in Endothelial Dysfunction-Associated Pathways in the Nitrofen-Induced Congenital Diaphragmatic Hernia Model. J Vasc Res. 2018;55(1):26-34.
产品手册
关联产品
-
LSZ102
LSZ102 is a potent, orally bioavailable, selective estrogen receptor degrader (SERD) with ERα transcription IC50 of 6 nM and ERα degradation IC50 of 0.2 nM.
-
GDC-0927 R-form
GDC-0927 (SRN-927, RG-6047) is a potent, orally bioavailable, selective estrogen receptor degrader (SERD).
-
SNG-1153
A derivate of icaritin that inhibits the growth of lung CSCs.
